Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 1-9 , 30 October 2009

Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher–Bickerstaff syndrome)

  • Nobuhiro Yuki

      Affiliations

    • Corresponding Author InformationTel.: +81 257 22 2126; fax: +81 257 22 7487.

Received 9 March 2009 ,Revised 8 May 2009 ,Accepted 29 May 2009.

References 

  1. Al-Din AN, Anderson M, Bickerstaff ER, Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982;105:481–495
  2. Ang CW, Jacobs BC, Laman JD. The Guillain–Barré syndrome: a true case of molecular mimicry. Trends Immunol. 2004;25:61–66
  3. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27:S21–24Suppl
  4. Aspinall GO, McDonald AG, Pang H, Kurjanczyk LA, Penner JL. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain–Barré syndrome. Biochemistry. 1994;33:241–249
  5. Bickerstaff ER. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. Br Med J. 1957;1384–1387
  6. Bickerstaff ER, Cloake PC. Mesencephalitis and rhombencephalitis. Br. Med. J. 1951;ii:4723:77–81
  7. Buchwald B, Bufler J, Carpo M, Heidenreich F, Pitz R, Dudel J, et al. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology. 2001;56:67–74
  8. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 1992;31:677–679
  9. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain–Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–1917
  10. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997;745:32–36
  11. Faraci FM, Choi J, Baumbach GL, Mayhan WG, Heistad DD. Microcirculation of the area postrema: permeability and vascular responses. Circ. Res. 1989;65:417–425
  12. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 1956;255:57–65
  13. Funakoshi K, Kuwabara S, Odaka M, Hirata K, Yuki N. Clinical predictors of mechanical ventilation in Fisher/Guillain–Barré overlap syndrome. J. Neurol. Neurosurg. Psychiatry. 2009;80:60–64
  14. Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, et al. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni: biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem. 2002;277:327–337
  15. Giroud M, Mousson C, Chalopin JM, Rifle G, Dumas R. Miller-Fisher [sic] syndrome and pontine abnormalities on MRI: a case report. J. Neurol. 1990;237:489–490
  16. Gong Y, Tagawa Y, Lunn MP, Laroy W, Heffer-Lauc M, Li CY, et al. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain. 2002;125:2491–2506
  17. Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, et al. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J. Neurosci. 2005;25:1620–1628
  18. Hafer-Macko C, Hsieh S-T, Li CY, Ho TW, Sheikh K, Cornblath DR, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 1996;40:635–644
  19. Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 1996;39:625–635
  20. Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC, et al. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain. 2008;131:1197–1208
  21. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré syndrome. Ann. Neurol. 1999;45:168–173
  22. Houliston RS, Koga M, Li J, Jarrell HC, Richards JC, Vitiazeva V, et al. A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry. 2007;46:8164–8171
  23. Hughes RAC, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain–Barré syndrome: a systematic review. Brain. 2007;130:2245–2257
  24. Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J. Neurol. 2008;255:674–682
  25. Jamal GA, Ballantyne JP. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome): a serial multimodal neurophysiological study. Brain. 1988;111(Pt 1):95–114
  26. Kaida K, Kanzaki M, Morita D, Kamakura K, Motoyoshi K, Hirakawa M, et al. Anti-ganglioside complex antibodies in Miller Fisher syndrome. J. Neurol. Neurosurg. Psychiatry. 2006;77:1043–1046
  27. Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K, et al. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain–Barré syndromes. J. Neurol. Neurosurg. Psychiatry. 2008;79:1148–1152
  28. Kimoto K, Koga M, Odaka M, Hirata K, Takahashi M, Li J, et al. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology. 2006;67:1837–1843
  29. Koga M, Yoshino H, Morimatsu M, Yuki N. Anti-GT1a IgG in Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 2002;72:767–771
  30. Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K, et al. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology. 2005;64:1605–1611
  31. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain–Barré syndrome. Neurology. 2005;65:1376–1381
  32. Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, et al. Comprehensive analysis of bacterial risk factors for the development of Guillain–Barré syndrome after Campylobacter jejuni enteritis. J. Infect. Dis. 2006;193:547–555
  33. Kornberg AJ, Pestronk A, Blume GM, Lopate G, Yue J, Hahn A. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher [sic] and related syndromes. Neurology. 1996;47:1317–1320
  34. Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve. 1999;22:1071–1074
  35. Kuwabara S, Asahina M, Nakajima M, Mori M, Fukutake T, Hattori T, et al. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann. Neurol. 1999;45:533–536
  36. Kuwabara S, Misawa S, Takahashi H, Sawai S, Kanai K, Nakata M, et al. Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle. J. Neuroimmunol. 2007;189:158–162
  37. Lange DJ, DeAngelis T, Sivak MA. Single-fiber electromyography shows terminal axon dysfunction in Miller Fisher syndrome: a case report. Muscle Nerve. 2006;34:232–234
  38. Liu JX, Willison HJ, Pedrosa-Domellof F. Immunolocalisation of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci. 2009;50:3226–3232
  39. Lo YL, Leoh TH, Dan YF, Lim LL, Seah A, Fook-Chong S, et al. Presynaptic neuromuscular transmission defect in the Miller Fisher syndrome. Neurology. 2006;66:148–149
  40. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56:1104–1106
  41. Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology. 2007;68:1144–1146
  42. Mori M, Koga M, Yuki N, Hattori T, Kuwabara S. Bickerstaff's brainstem encephalitis after an outbreak of Campylobacter jejuni enteritis. J. Neuroimmunol. 2008;196:143–146
  43. Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Continuous spectrum of pharyngeal–cervical–brachial variant of Guillain–Barré syndrome. Arch. Neurol. 2007;64:1519–1523
  44. Najim Al-Din AS. The nosological position of the ophthalmoplegia, ataxia and areflexia syndrome: “the spectrum hypothesis”. Acta Neurol. Scand. 1987;75:287–294
  45. Nam Shin JE, Ackloo S, Mainkar AS, Monteiro MA, Pang H, Penner JL, et al. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10: structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher [sic] syndrome and from the serotype reference strain. Carbohydr. Res. 1997;305:223–232
  46. Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J. Neuroimmunol. 2004;148:200–205
  47. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J. Neurol. Neurosurg. Psychiatry. 2001;70:50–55
  48. Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome. Brain. 2003;126:2279–2290
  49. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain–Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol. 2000;48:624–631
  50. Ogawara K, Kuwabara S, Yuki N. Fisher syndrome or Bickerstaff brainstem encephalitis: anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems. Muscle Nerve. 2002;26:845–849
  51. O'Leary CP, Veitch J, Durward WF, Thomas AM, Rees JH, Willison HJ. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiatry. 1996;61:649–651
  52. Overell J, Hsieh S, Odaka M, Yuki N, Willison H. Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database Syst Rev. 2007;1:CD004761
  53. Phongsisay V, Susuki K, Matsuno K, Yamahashi T, Okamoto S, Funakoshi K, et al. Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain–Barré syndrome. J. Neuroimmunol. 2008;205:101–104
  54. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain–Barré syndrome. N. Engl. J. Med. 1995;333:1374–1379
  55. Ropper AH. The CNS in Guillain–Barré syndrome. Arch. Neurol. 1983;40:397–398
  56. Ropper AH, Shahani B. Proposed mechanism of ataxia in Fisher's syndrome. Arch. Neurol. 1983;40:537–538
  57. Schluep M, Steck AJ. Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology. 1988;38:1890–1892
  58. Susuki K, Yuki N, Hirata K. Fine specificity of anti-GQ1b IgG and clinical features. J. Neurol. Sci. 2001;185:5–9
  59. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 2007;27:3956–3967
  60. Takahashi M, Koga M, Yokoyama K, Yuki N. Epidemiology of Campylobacter jejuni isolated from patients with Guillain–Barré and Fisher syndromes in Japan. J. Clin. Microbiol. 2005;43:335–339
  61. Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, et al. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. J. Neuroimmunol. 2006;177:201–208
  62. Urushitani M, Udaka F, Kameyama M. Miller Fisher–Guillain–Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts. J. Neurol. Neurosurg. Psychiatry. 1995;58:241–243
  63. van Breemen VL, Clemente CD. Silver deposition in the central nervous system and the hematoencephalic barrier studied with the electron microscope. J. Biophys. Biochem. Cytol. 1955;1:161–166
  64. Willison HJ, O'Hanlon GM. The immunopathogenesis of Miller Fisher syndrome. J. Neuroimmunol. 1999;100:3–12
  65. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 1994;50:159–165
  66. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry. 1993;56:204–206
  67. Willison HJ, O'Hanlon GM, Paterson G, Veitch J, Wilson G, Roberts M, et al. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1–18. J. Clin. Invest. 1996;97:1155–1164
  68. Willison HJ, Townson K, Veitch J, Boffey J, Isaacs N, Andersen SM, et al. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain. 2004;127:680–691
  69. Willison HJ, Halstead SK, Beveridge E, Zitman FM, Greenshields KN, Morgan BP, et al. The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain–Barre syndrome. J. Neuroimmunol. 2008;201–202:172–182
  70. Willison HJ, Halstead SK, Beveridge E, Zitman FM, Greenshields KN, Morgan BP, et al. The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain–Barré syndrome. J. Neuroimmunol. 2008;201–202:172–182
  71. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann. Neurol. 1996;39:668–672
  72. Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: a new approach to treatment. Neurology. 1996;46:1644–1651
  73. Yuki N. Infectious origins of, and molecular mimicry in, Guillain–Barré and Fisher syndromes. Lancet. Infect. Dis. 2001;1:29–37
  74. Yuki N, Tsujino Y. Familial Guillain–Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Pediatr. 1995;126:162
  75. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J. Neurol. Sci. 1993;118:83–87
  76. Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 1993;43:414–417
  77. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, et al. A bacterium lipopolysaccharide that elicits Guillain–Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 1993;178:1771–1775
  78. Yuki N, Taki T, Takahashi M, Saito K, Yoshino H, Tai T, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 1994;36:791–793
  79. Yuki N, Ichihashi Y, Taki T. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain–Barré syndrome. J. Neuroimmunol. 1995;60:161–164
  80. Yuki N, Susuki K, Hirata K. Ataxic Guillain–Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology. 2000;54:1851–1853
  81. Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology. 2001;108:196–200
  82. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, et al. Animal model of axonal Guillain–Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 2001;49:712–720
  83. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome. Proc. Natl. Acad. Sci. U. S. A. 2004;101:11404–11409
  84. Zhang G, Lopez PH, Li CY, Mehta NR, Griffin JW, Schnaar RL, et al. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain. 2004;127:1085–1100

PII: S0165-5728(09)00230-6

doi: 10.1016/j.jneuroim.2009.05.020

Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 1-9 , 30 October 2009

Article Tools

* Image Usage & Resolution